The molecular defect in patients with mitochondrial myopathies (MM) commonly involves the mitochondrial genome, with either single, large-scale deletions, or point mutations, resulting in mosaicism of MRC-competent and MRC-affected muscle fibers [22]. This evidence concerns the gene CD200 and Mitochondrial myopathy.